Managementul și inversarea anticoagulării

Reversal of antithrombotic agents. (se deschide o fereastră nouă)

Bauer KA.

Sursă‎: Am J Hematol 2012;87 Suppl 1:S119-26.

Index‎: PubMed 22460529

DOI‎: 10.1002/ajh.23165

https://www.ncbi.nlm.nih.gov/pubmed/22460529 (se deschide o fereastră nouă)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (se deschide o fereastră nouă)

Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M

Sursă‎: J Thromb Haemost 2015;13(10):1790-8.

Index‎: PubMed 26270886

DOI‎: 10.1111/jth.13117

https://www.ncbi.nlm.nih.gov/pubmed/26270886 (se deschide o fereastră nouă)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (se deschide o fereastră nouă)

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators

Sursă‎: N Engl J Med 2019;380(14):1326-35.

Index‎: PubMed 30730782

DOI‎: 10.1056/NEJMoa1814051

https://www.ncbi.nlm.nih.gov/pubmed/30730782 (se deschide o fereastră nouă)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (se deschide o fereastră nouă)

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators

Sursă‎: N Engl J Med 2016;375(12):1131-41.

Index‎: PubMed 27573206

DOI‎: 10.1056/NEJMoa1607887

https://www.ncbi.nlm.nih.gov/pubmed/27573206 (se deschide o fereastră nouă)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (se deschide o fereastră nouă)

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M

Sursă‎: Circulation 2011;124(14):1573-9.

Index‎: PubMed 21900088

DOI‎: 10.1161/CIRCULATIONAHA.111.029017

https://www.ncbi.nlm.nih.gov/pubmed/21900088 (se deschide o fereastră nouă)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (se deschide o fereastră nouă)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Sursă‎: Lancet 2015;385(9982):2077-87.

Index‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (se deschide o fereastră nouă)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (se deschide o fereastră nouă)

Gordon JL, Fabian TC, Lee MD, Dugdale M

Sursă‎: J Trauma Acute Care Surg 2013;75(3):475-86.

Index‎: PubMed 24089118

DOI‎: 10.1097/TA.0b013e3182a07391

https://www.ncbi.nlm.nih.gov/pubmed/24089118 (se deschide o fereastră nouă)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (se deschide o fereastră nouă)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Sursă‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Index‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (se deschide o fereastră nouă)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (se deschide o fereastră nouă)

Levi M, Eerenberg E, Kamphuisen PW.

Sursă‎: J Thromb Haemost 2011;9(9):1705-12.

Index‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (se deschide o fereastră nouă)

Emergency reversal of warfarin anticoagulation. (se deschide o fereastră nouă)

Lin Y, Callum J.

Sursă‎: CMAJ 2010;182(18):2004.

Index‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (se deschide o fereastră nouă)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (se deschide o fereastră nouă)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Sursă‎: Thromb Haemost 2012;108(2):217-24.

Index‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (se deschide o fereastră nouă)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (se deschide o fereastră nouă)

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

Sursă‎: J Thromb Haemost 2008;6(4):622-31.

Index‎: PubMed 18208533

DOI‎: 10.1111/j.1538-7836.2008.02904.x

https://www.ncbi.nlm.nih.gov/pubmed/18208533 (se deschide o fereastră nouă)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (se deschide o fereastră nouă)

Piran S, Khatib R, Schulman S, Majeed A, Holbrook A, Witt DM, Wiercioch W, Schünemann HJ, Nieuwlaat R

Sursă‎: Blood Adv 2019;3(2):158-67.

Index‎: PubMed 30658963

DOI‎: 10.1182/bloodadvances.2018024133

https://www.ncbi.nlm.nih.gov/pubmed/30658963 (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal. (se deschide o fereastră nouă)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Sursă‎: N Engl J Med 2015;373(6):511-20.

Index‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal - full cohort analysis. (se deschide o fereastră nouă)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Sursă‎: N Engl J Med 2017;377(5):431-41.

Index‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (se deschide o fereastră nouă)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (se deschide o fereastră nouă)

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B

Sursă‎: Blood 2003;102(13):4594-9.

Index‎: PubMed 12920042

DOI‎: 10.1182/blood-2002-11-3566

https://www.ncbi.nlm.nih.gov/pubmed/12920042 (se deschide o fereastră nouă)

Role of agents for reversing the effects of target-specific oral anticoagulants. (se deschide o fereastră nouă)

Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS

Sursă‎: Am J Health Syst Pharm 2017;74(2):54-61.

Index‎: PubMed 27895055

DOI‎: 10.2146/ajhp150810

https://www.ncbi.nlm.nih.gov/pubmed/27895055 (se deschide o fereastră nouă)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (se deschide o fereastră nouă)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Sursă‎: Anesth Analg 2011;113(4):703-10.

Index‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (se deschide o fereastră nouă)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (se deschide o fereastră nouă)

Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS

Sursă‎: J Am Coll Cardiol 2017;70(24):3042-67.

Index‎: PubMed 29203195

DOI‎: 10.1016/j.jacc.2017.09.1085

https://www.ncbi.nlm.nih.gov/pubmed/29203195 (se deschide o fereastră nouă)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (se deschide o fereastră nouă)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Sursă‎: World Neurosurg 2014;81(1):110-5.

Index‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (se deschide o fereastră nouă)

Reversal of warfarin-induced hemorrhage in the emergency department. (se deschide o fereastră nouă)

Zareh M, Davis A, Henderson S.

Sursă‎: West J Emerg Med 2011;12(4):386-92.

Index‎: PubMed 22224125

DOI‎: 10.5811/westjem.2011.3.2051

https://www.ncbi.nlm.nih.gov/pubmed/22224125 (se deschide o fereastră nouă)

TERAPIE INTENSIVĂ

Managementul și inversarea anticoagulării

Română

Managementul și inversarea anticoagulării

https://assetsnffrgf-a.akamaihd.net/assets/ct/e781f8601f/images/syn_placeholder_sqr.png

Managementul și inversarea anticoagulării

Reversal of antithrombotic agents. (se deschide o fereastră nouă)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (se deschide o fereastră nouă)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (se deschide o fereastră nouă)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (se deschide o fereastră nouă)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (se deschide o fereastră nouă)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (se deschide o fereastră nouă)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (se deschide o fereastră nouă)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (se deschide o fereastră nouă)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (se deschide o fereastră nouă)

Emergency reversal of warfarin anticoagulation. (se deschide o fereastră nouă)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (se deschide o fereastră nouă)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (se deschide o fereastră nouă)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal. (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal - full cohort analysis. (se deschide o fereastră nouă)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (se deschide o fereastră nouă)

Role of agents for reversing the effects of target-specific oral anticoagulants. (se deschide o fereastră nouă)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (se deschide o fereastră nouă)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (se deschide o fereastră nouă)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (se deschide o fereastră nouă)

Reversal of warfarin-induced hemorrhage in the emergency department. (se deschide o fereastră nouă)

Contactați un reprezentant local al Comitetului de legătură cu spitalele

Materiale medicale informative

Materiale video

Managementul și inversarea anticoagulării

Selectaţi limba dorită

Partajează